Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00257894Phase 2Terminated
Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Baclofen with Placebo (2 arms). Primary endpoints: Questionnaire of Smoking Urges at Day 10 and Minnesota Nicotine Withdrawal Questionnaire at Day 10. Started Dec 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00257894.